Science Explorer Interactive view Map
Company · Basel · Switzerland

NBE Therapeutics (Switzerland)

nbe-therapeutics.com/template/index.phpROR OpenAlex
Research works
28
▲ 49% vs 2013–17
Citations
590
20.8 per fractional work
Top-10% rate
17.6%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: NBE Therapeutics (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.82× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.10× its world share, 1 worksImmunology and Micro…Neuroscience: 2.38× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.83× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.78× its world share, 0 worksChemistryComputer Science: 0.20× its world share, 0 worksComputer ScienceEngineering: 0.28× its world share, 0 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.10× its world share, 0 worksHealth ProfessionsMedicine: 2.75× its world share, 7 worksMedicineEconomics, Econometrics and Finance: 0.60× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.1×. Every wedge is a field page.

Who are the top researchers at NBE Therapeutics (Switzerland)?

Ranked on the composite score, Roger R. Beerli lead among researchers whose main affiliation is NBE Therapeutics (Switzerland).

  1. 1 Roger R. Beerli Switzerland · #283,511 worldwide 442 citations · 15 works
All ranked researchers at NBE Therapeutics (Switzerland)

Which keywords describe research at NBE Therapeutics (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Fc Receptors, Therapeutic Antibodies, Chemotherapy, Monoclonal Antibody, Breast Cancer and HER2.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Glycosylation4▲ 73×3 topics
  2. Monoclonal Antibodies4▲ 103×2 topics
  3. Fc Receptors4▲ 134×1 topic
  4. Therapeutic Antibodies4▲ 103×1 topic
  5. Chemotherapy3▲ 17×6 topics
  6. Monoclonal Antibody3▲ 158×2 topics
  7. Breast Cancer3▲ 37×3 topics
  8. HER23▲ 331×1 topic
  9. Trastuzumab3▲ 235×1 topic
  10. Cancer Immunotherapy3▲ 70×3 topics
  11. Immunotherapy3▲ 15×5 topics
  12. Tumor Regression2▲ 100×2 topics
  13. Lymphoma2▲ 54×2 topics
  14. Cancer2▲ 5.4×7 topics
  15. CAR T Cells2▲ 173×1 topic
  16. Chimeric Antigen Receptor2▲ 173×1 topic
  17. Cyclotides2▲ 327×1 topic
  18. Sortase2▲ 327×1 topic
  19. Inflammation2▲ 2.5×8 topics
  20. Tumor Microenvironment1▲ 14×4 topics
  21. Antioxidant1▲ 7.0×2 topics
  22. Homologous Recombination1▲ 66×2 topics
  23. Cancer Therapy1▲ 6.3×5 topics
  24. Drug Discovery1▲ 9.6×3 topics
  25. Transcriptional Regulation1▲ 16×3 topics

Which research topics does NBE Therapeutics (Switzerland) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, DNA Repair Mechanisms and Nuclear Receptors and Signaling.

CAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksDNA Repair Mechanisms: 1 fractional worksNuclear Receptors and Signaling: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksCancer Research and Treatments: 0 fractional worksCell Adhesion Molecules Research: 0 fractional worksColorectal Cancer Treatments and Studies: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingMolecular BiologyCellular and Molecular Neuroscience3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 DNA Repair Mechanisms Molecular Biology 1 works
  4. 4 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 Peptidase Inhibition and Analysis Oncology 0 works
  8. 8 Cancer Research and Treatments Biotechnology 0 works
  9. 9 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  10. 10 Colorectal Cancer Treatments and Studies Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.7%not open54.3%

World: 28% of research is openly available.

with international co-authors37.6%domestic only62.4%

World: 19% is written across borders.

How has NBE Therapeutics (Switzerland)'s research output changed?

Output in 2018–2022 was 49% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Basel

All research institutions in Basel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.